BAG3 is a highly conserved protein having pleiotropic effects that is expressed at high levels in the heart, skeletal muscles, and many cancers. BAG3 may prove to be a new therapeutic target in the treatment of heart failure.
SUMMARY
Mutations in Bcl-2-associated athanogene 3 (BAG3) were associated with skeletal muscle dysfunction and dilated cardiomyopathy. Retro-orbital injection of an adeno-associated virus serotype 9 expressing BAG3 (rAAV9-BAG3) significantly (p < 0.0001) improved left ventricular ejection fraction, fractional shortening, and stroke volume 9 days post-injection in mice with cardiac dysfunction secondary to a myocardial infarction. 
B
-cell lymphoma 2 (Bcl-2)-associated anthanogene-3 (BAG3), a 575 amino acid member of the BAG family of proteins, is expressed at high levels in the heart, in the vasculature, and in many cancers (1) . BAG3 plays an important role in protein quality control by serving as a co-chaperone for the heat shock proteins and attenuates apoptosis by binding to Bcl-2, which in turn leads to resistance to chemotherapy in cancer cells (2) . In muscle, BAG3 also binds to capping protein (CapZ) to tether actin filaments to the Z-disc. That BAG3 plays a critical role in cardiac homeostasis was first shown by studies reporting that a heterozygous p.Pro209Leu mutation was associated with progressive limb and axial muscle weakness, severe respiratory insufficiency, and cardiomyopathy in children (3, 4) . Subsequent studies identified an association between deletions in BAG3 and the development of left ventricular (LV) dysfunction and cardiac dilation independent of peripheral muscle weakness in individuals with familial dilated cardiomyopathy (5, 6) . Decreased levels of BAG3 were also found in the ventricular myocardium of patients with end-stage heart failure (HF) and reduced ejection fraction due to either coronary artery disease or to idiopathic dilated cardiomyopathy (5) .
Homozygous deletion of BAG3 in mice led to severe LV dysfunction, myofibril disorganization, and death by 4 weeks of age (7); however, the molecular mechanisms responsible for regulation of BAG3 function in the heart are just beginning to be understood. From the a Department of Biology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania; mice with LV dysfunction secondary to a myocardial infarction (MI). These studies suggest that BAG3 could be a novel target for therapeutic intervention in patients with HF with reduced ejection fraction.
METHODS
ANIMAL PROTOCOLS. Eight-week old male C57BL/6J mice (Jackson Laboratory, Bar Harbor, Maine) were randomly assigned to undergo an induction of an MI by left coronary artery ligation using a protocol described previously by our group that led to a significant reduction in LV function with generally acceptable levels of long-term survival (10, 11 Calsequestrin was used to determine protein loading in quantitative Western blots, whereas GAPDH was used for nonquantitative blots. Secondary antibodies were: goat antimouse IRDye 800 (LiCor) and
IRDye 680 goat antirabbit (Rockland, Gilbertsville, Pennsylvania).
ISOLATION OF ADULT MURINE CARDIAC MYOCYTES.
In a subset of the study cohort, cardiac myocytes were isolated from the septum and LV free wall according to the protocol of Zhou et al. (14) and plated on laminin-coated glass coverslips (15) . Coverslips containing myocytes were mounted in a DvorakStotler chamber, and bathed in fresh media before measurements.
Knezevic et al. , and field stimulated to contract (2 Hz; 37 C), as described previously (9) . In brief, myocytes were exposed to excitation light (360 and 380 nm) only during data acquisition. Epifluorescence (510 nm) was measured in steady-state twitches both before and after the addition of isoproterenol (1 mmol/l) (15) (16) (17) (18) (19) (20) . For contraction measurements, images of myocytes (not loaded with fura-2) were captured by a charge-coupled device video camera, and myocyte motion was analyzed offline with an edge detection algorithm (15) (16) (17) (18) (19) (20) .
CONFOCAL MICROSCOPY. Confocal microscopy was used to detect BAG3 localization in adult cardiomyocytes as described previously (9) . Briefly, Knezevic et al.
for 60 min. A Carl Zeiss 710 confocal microscope (63Â oil objective) with ZEN software was used for imaging. Total laser intensity and photomultiplier gain were set constant for all groups and settings, and data were verified by 2 independent observers who were blinded to the experimental group. Three coverslips were used for each experimental group and at least 3 cell images were acquired from each coverslip.
REAL-TIME POLYMERASE CHAIN REACTION
MEASUREMENT OF BRAIN NATRIURETIC PEPTIDE.
Total messenger ribonucleic acid (mRNA) was isolated from a randomly selected group of sham or MI mice as Table 1) . Importantly, injection of rAAV9-BAG3 had no effect on LVEF in Sham mice when compared with Sham mice that received rAAV9-GFP. It is also noteworthy that there was no statistical difference in LVEF between MI-BAG3 and -GFP mice at weeks 1, 3, 5, or 7-all of which were prior to the injection of rAAV9-BAG3 or -GFP at week 8.
Preliminary studies had demonstrated that the fall in ejection fraction post-MI in our model plateaued between weeks 5 and 7. Therefore, we chose to inject AAV9-BAG3 at week 8, a time when the EF was relatively stable, to optimize our ability to assess the effects of rAAV9-BAG3. Also, it should be noted that there were no deaths in mice randomized to any of the 4 treatment groups after injection of either rAAV9-BAG3 or -GFP.
As we have previously observed in other models of HF (1), levels of BAG3 were significantly diminished in MI-GFP mice at 11 weeks post-MI compared with Sham-GFP mice (p < 0.04); however, MI-BAG3 mice had significantly elevated levels of BAG3 compared with MI-GFP mice (p < 0.04) ( Figure 1C) . Consistent with earlier findings in our laboratory (9), BAG3 was found predominantly in the sarcolemma and t-tubules of Sham-GFP myocytes. BAG3 levels were reduced in MI-GFP myocytes. Importantly, not only did rAAV9-BAG3 injection reconstitute BAG3 levels, but the exogenous BAG3 was also correctly targeted to the sarcolemma and t-tubules of MI-BAG3 myocytes ( Figures 1D to 1F ).
We did not measure BNP levels as part of our original protocol; however, we were able to assess levels of BNP in a subgroup of MI-BAG3 and -GFP hearts. There was a trend toward a decrease in BNP mRNA levels in the hearts of MI mice that received rAAV9-BAG3 RCL ¼ resting call length; other abbreviations as in Figure 1 . 
